2-es típusú cukorbetegség: vizsgálatok itt: Mexikó
27 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Mérida, México, Mexico City, Monterrey, Torreón, Veracruz
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Ciudad Madero, Col Saucito, Cuernavaca, Delegacion Cuauhtemoc, Guadalajara, México, San Pedro Garza García
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Ciudad Madero, Col Saucito, Cuernavaca, Delegacion Cuauhtemoc, Guadalajara, México, San Pedro Garza García
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Cuernavaca, Mexico City, Monterrey
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Ciudad Madero, Guadalajara, Monterrey
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Guadalajara, Mérida, Monterrey
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Chihuahua City, Guadalajara, Huixquilucan, Mexicali, Mexico City, Monterrey
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisNot yet taking people in MexikóA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Actopan, Cuernavaca, Culiacán, Durango, Guadalajara, León, México, Mexico City, Monterrey, Querétaro
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Cuernavaca, Guadalajara, Monterrey, San Luis Potosí City, Zapopan
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - No phaseTaking peopleContinuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
- Where
- Mexico City
- Életkor
- 40 év to 70 év
- People
- 110
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT06069518 - No phaseNot yet taking people in MexikóA Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 800
- Run by
- Bayer
See details and how to joinNCT07841015 - 3. fázisTaking peopleA Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Where
- Coyoacán, Cuauhtémoc, Monterrey, Puebla City, San Nicolás de los Garza
- Életkor
- 10 év to 18 év
- People
- 80 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07282613 - No phaseTaking peopleBody Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 200
- Run by
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
See details and how to joinNCT07835360 - No phaseCsak meghívásosGlycemic Control and the Ask Me 3® Educational Program
- Where
- San Nicolás de los Garza
- Életkor
- 18 év to 80 év
- People
- 250
- Run by
- Maria Elena Romero Ibarguengoitia
See details and how to joinNCT07678671 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Iztapalapa, León, México, Mexico City
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Chihuahua City, Cuernavaca, Guadalajara, Mexico City, Monterrey, Zapopan
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Ciudad Madero, Guadalajara, Hermosillo, Mérida, Merida Centro, Monterrey, Tlalpan
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleMetformin Effects According to SLC16A11 Carrier Status
- Where
- Mexico City
- Életkor
- 18 év to 65 év
- People
- 154
- Run by
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
See details and how to joinNCT07760883 - 3. fázisTaking peopleA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Where
- Ciudad Madero, Puebla City, Tampico, Tlalpan, Veracruz
- Életkor
- 10 év to 17 év
- People
- 55 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06739122 - 3. fázisNot yet taking people in MexikóBALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
- Where
- Guadalajara, Mexico City, Monterrey, Oaxaca City, Pachuca
- Életkor
- 18 év and over
- People
- 374
- Run by
- Carnot Laboratories
See details and how to joinNCT07628985 - No phaseNot yet taking people in MexikóCARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 30
- Run by
- JULIO GRANADOS MONTIEL
See details and how to joinNCT07567378 - No phaseNot yet taking people in MexikóCohort Study of Metabolic Disease and Hypertension
- Where
- Mexico City
- Életkor
- 18 év to 65 év
- People
- 2500
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT07577063 - 4. fázisTaking peopleEffects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- Where
- Monterrey
- Életkor
- 18 év and over
- People
- 62
- Run by
- Hospital Universitario Dr. Jose E. Gonzalez
See details and how to joinNCT07401992 - No phaseCsak meghívásosType 2 Diabetes and Associated Factors in Mexico
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Coordinación de Investigación en Salud, Mexico
See details and how to joinNCT07248891 - No phaseCsak meghívásosEffect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico
- Where
- Oaxaca City
- Életkor
- 30 év to 70 év
- People
- 160
- Run by
- Universidad Autónoma Benito Juárez de Oaxaca
See details and how to joinNCT06683235